dexmethylphenidate hydrochloride
dexmethylphenidate hydrochloride is listed in the FDA National Drug Code directory with 80 NDC codes, marketed under brand names including Focalin XR, Dexmethylphenidate Hydrochloride Extended-Release, Dexmethylphenidate Hydrochloride. Available dosage forms: capsule, extended release, tablet, powder.
Drug details
- Generic Name
- dexmethylphenidate hydrochloride
- Brand Names
- Focalin XR, Dexmethylphenidate Hydrochloride Extended-Release, Dexmethylphenidate Hydrochloride, Focalin, DEXMETHYLPHENIDATE HYDROCHLORIDE
- Application Number
- NDA021802
- Sponsor
- Sandoz Inc
- NDC Codes
- 80
- Dosage Forms
- CAPSULE, EXTENDED RELEASE, TABLET, POWDER
- Routes
- ORAL
- Active Ingredients
- DEXMETHYLPHENIDATE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Dexmethylphenidate hydrochloride extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies ( 14 )] . Limitations of Use The use of dexmethylphenidate hydrochloride extended-release capsules is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions ( 5.7 ), Use in Specific Populations ( 8.4 )] . Dexmethylphenidate hydrochloride extended-release capsules are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) ( 1 ). Limitations of Use The use of dexmethylphenidate hydrochloride extended-release capsules is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage ( 5.7 , 8.4 ).